| Literature DB >> 35335214 |
Iva Slavova1, Teodora Tomova1, Slavena Kusovska1, Yoana Chukova1, Mariana Argirova1.
Abstract
Tamus communis L. is a plant distributed in a number of geographical areas whose rhizome has been used for centuries as an anti-inflammatory and analgesic remedy. This review aims to summarize the current knowledge of the chemical composition and biological activity of the extracts or individual compounds of the rhizome. The data for the principal secondary metabolites are systematized: sterols, steroidal saponins, phenanthrenes, dihydrophenanthrenes, etc. Results of biological tests for anti-inflammatory action, cytotoxicity, anticholinesterase effect, and xanthine oxidase inhibition are presented. Some open questions about the therapeutic properties of the plant are also addressed.Entities:
Keywords: Tamus communis rhizome; anti-inflammatory; cholinesterase inhibitor; cytotoxicity; diosgenin; phenanthrenes; sterols; xanthin oxidase inhibitor
Mesh:
Substances:
Year: 2022 PMID: 35335214 PMCID: PMC8949886 DOI: 10.3390/molecules27061851
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Tamus communis L. (a) aerial part; (b) rhizome (authors’ photos).
Compounds isolated from organic extracts of Tamus communis rhizome.
| Compound | Data | Reference |
|---|---|---|
| m.p., UV, 1H-NMR | [ | |
| m.p., UV, 1H-NMR | [ | |
| m.p., UV, 1H-NMR | [ | |
| 1H-NMR | [ | |
| 1H-NMR | [ | |
| m.p., 1H-NMR | [ | |
| m.p., 1H-NMR | [ | |
| m.p., UV, MS, 1H-NMR | [ | |
| m.p., UV, MS, 1H-NMR | [ | |
| m.p., UV, MS, 1H-NMR | [ | |
| m.p., UV, MS, 1H-NMR | [ | |
| m.p., UV, MS, 1H-NMR | [ | |
| UV, 1H-NMR, 13C-NMR, MS, | [ | |
| UV, 1H-NMR, 13C-NMR, MS, | [ | |
| Rf, 1H-NMR, 13C-NMR, MS | [ | |
| Rf, 1H-NMR, 13C-NMR, MS | [ | |
| m.p., UV, MS, 1H-NMR, 13C-NMR | [ | |
| m.p., UV, MS, 1H-NMR, 13C-NMR | [ | |
| Rf, UV, MS, 1H-NMR, 13C-NMR | [ | |
| Rf, UV, MS, 1H-NMR, 13C-NMR | [ | |
| m.p., 1H-NMR, MS | [ | |
| m.p., 1H-NMR, MS | [ | |
| m.p., 1H-NMR, MS | [ | |
| HPLC | [ | |
| MS,1H-NMR, 13C-NMR | [ | |
| MS,1H-NMR, 13C-NMR | [ |
m.p.—melting point, Rf—retention factor.
Concentrations of some phenolic compounds of TCR extract in CHCl3.
| Compound | Concentration (in mg Per 1 g Dry Extract) |
|---|---|
| Total phenols | 167 GAE |
| Phenolic acids | |
| Gallic acid | 0.43 |
| Protocatehuic acid | BLD |
| Chlorogenic acid | ND |
| Vanillic acid | 0.89 |
| Caffeic acid | NF |
| Syringic acid | 2.95 |
| p-Coumaric acid | BLD |
| Ferulic acid | 0.21 |
| Salicylic acid | 0.27 |
| Rosmarinic acid | 0.41 |
| Flavonoids | 15.6 QE |
| Rutin | ND |
| Hesperidin | ND |
| (+)-Catechin | 0.54 |
| (−)-Epicatechin | 0.72 |
| Quercetin | 0.38 |
| Kaempherol | 9.98 |
| Tannins | 12.64 TAE |
GAE, gallic acid equivalents; QE, quercetin equivalents, TAE, tannic acid equivalents; ND, not detected; BLD, below the limit of detection.
Biological activity of Tamus communis rhizome extracts and some of individual phytochemicals.
| Extract/Compound | Model Used | Biological Activity | Reference |
|---|---|---|---|
| Extract in 80% EtOH | Rats, oral administration | Anti-inflammatory, analgesic | [ |
| Extract in 80% EtOH | Rats (cotton pellet-induced granuloma) | Anti-inflammatory | [ |
| 1% extract in EtOH | Rats (carrageenan-induced edema) | Anti-inflammatory | [ |
| Extract in EtOH and H2O | Rats, oral administration | Anti-inflammatory, antinocieptive | [ |
|
| HeLa cell line * | Cytotoxicity | [ |
| Extract in 80% EtOH | Hep-2 & AMN-3 cell lines * | Cytotoxicity | [ |
|
| Hep-2 & AMN-3 cell lines * | Cytotoxicity | [ |
| Extract in CHCl3 |
| Antibacterial | [ |
| Extract in AcOEt |
| Antibacterial | [ |
|
| Cells infected with VSV or HRV 1B * | Antiviral | [ |
| Extracts in MeOH, CHCl3 or AcOEt | Xanthine oxidase | Enzyme inhibition | [ |
|
| Xanthine oxidase | Enzyme inhibition | [ |
|
| Acetylcholine esterase | Enzyme inhibition | [ |
| Extract in Et2O | Butyrylcholine esterase | Enzyme inhibition | [ |
|
| Butyrylcholine esterase | Enzyme inhibition | [ |
| Extract in 85% MeOH | Mice, intraperitoneal administration | Improvement in antioxidant status | [ |
* HeLa, cervix adenocarcinoma cells; HEp-2, human epidermoid laryngocarcinoma cells; AMN-3, mammary adenocarcinoma cells; VSV, vesicular stomatitis virus; HRV 1B, human rhinovirus serotype.